Regeneron Pharma Jumps On Consensus-Smashing Quarter [Investor's Business Daily]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Investors Business Daily
Technology Related news 2/07/2018 Sanofi and Regeneron's Dupixent is off to a strong start in the U.S., but revenue from the eczema drug lagged... Why This Former Biotech Winner Is Now A Short-Sale Opportunity Generalists On Biotech Sidelines As Tax Reform Sweeps The U.S. Does Regeneron Pharma Have A Potential Blockbuster In 2018? U.S. Novel Drug Approvals Rocket Higher, But Overall Numbers Slide These 2 European Pharmas Grabbed Upgrades Ahead Of 2018 News Beware: Price Wars For Big Pharma, Biotech Companies On Horizon Why Biotech Stocks May Wait A While Before Feeling The Love Amgen, Regeneron Prep For Battle In 2018 Over Cholesterol Drugs Regeneron Pharmaceuticals ( REGN ) on Thursday reported adjusted income of $5.23 per share on sales of $1.58 billion for its fourth quarter, compared with $3.04 and $1.23 billion, respectively, in the year-ago period. X Analysts polled by Zacks Investment Research had called for Regeneron to
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Why Novavax Stock More Than Doubled Today [Yahoo! Finance]Yahoo! Finance
- Novavax's 146% Surge Delivers ‘Rib Crunching' Squeeze to Shorts [BNN Bloomberg (Canada)]BNN Bloomberg
- Novavax Stock Surges 140% on $1.4 Billion Deal With Sanofi [Yahoo! Finance]Yahoo! Finance
- Novavax hits a 52-week high as Sanofi deal prompts J.P. Morgan upgrade [Seeking Alpha]Seeking Alpha
- Novavax surges as Sanofi COVID vaccine deal boosts outlook [Seeking Alpha]Seeking Alpha
SNY
Analyst Actions
- 2/12/24 - TheStreet
SNY
Sec Filings
- 5/2/24 - Form 6-K
- 4/25/24 - Form 6-K
- 4/4/24 - Form F-3ASR
- SNY's page on the SEC website